Ramanjit Singh, Henrik Imberg, Shilan Seyed Ahmadi, Sara Hallström, Johan Jendle, Bengt-Olov Tengmark, Anna Folino, Ekström Marie, Marcus Lind
BACKGROUND: There are few studies providing a more comprehensive picture of advanced hybrid closed-loop (AHCL) systems in clinical practice. The aim was to evaluate the effects of the AHCL systems, Tandem® t: slim X2™ with Control IQ™, and MiniMed™ 780G, on glucose control, safety, treatment satisfaction, and practical barriers for individuals with type 1 diabetes. METHOD: One hundred forty-two randomly selected adults with type 1 diabetes at six diabetes outpatient clinics in Sweden at any time treated with either the Tandem Control IQ (TCIQ) or the MiniMed 780G system were included...
April 17, 2024: Journal of Diabetes Science and Technology